Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Mueller

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Cancer Research|October 15, 1994
Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell lineA M Montgomery, B M Mueller, R A Reisfeld, et al.
Cancer Research|January 1, 1991
Effect of a chimeric anti-ganglioside GD2 antibody on cell-mediated lysis of human neuroblastoma cellsE Barker, B M Mueller, R Handgretinger, et al.
Cancer Research|February 1, 1993
Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathwaysA M Montgomery, Y A De Clerck, K E Langley, et al.
The Journal of Clinical Investigation|November 5, 1999
Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitorE G Fischer, M Riewald, H Y Huang, et al.
Immunologic Research|June 14, 2000
Diverse functions of protease receptor tissue factor in inflammation and metastasisW Ruf, E G Fischer, H Y Huang, et al.
The Journal of Biological Chemistry|November 15, 1996
Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migrationM Yebra, G C Parry, S Strömblad, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
Proteases and protease inhibitors in tumor progressionY A DeClerck, S Imren, A M Montgomery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Suppression of human prostate carcinoma metastases in severe combined immunodeficient mice by interleukin 2 immunocytokine therapyC S Dolman, B M Mueller, H N Lode, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 11, 2000
Reversible regulation of tissue factor-induced coagulation by glycosyl phosphatidylinositol-anchored tissue factor pathway inhibitorI Ott, Y Miyagi, K Miyazaki, et al.
Biochemistry|January 28, 1992
Activation of methotrexate-alpha-alanine by carboxypeptidase A-monoclonal antibody conjugateE Haenseler, A Esswein, K S Vitols, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Cancer Research|October 15, 1994
Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell lineA M Montgomery, B M Mueller, R A Reisfeld, et al.
Cancer Research|January 1, 1991
Effect of a chimeric anti-ganglioside GD2 antibody on cell-mediated lysis of human neuroblastoma cellsE Barker, B M Mueller, R Handgretinger, et al.
Cancer Research|February 1, 1993
Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathwaysA M Montgomery, Y A De Clerck, K E Langley, et al.
The Journal of Clinical Investigation|November 5, 1999
Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitorE G Fischer, M Riewald, H Y Huang, et al.
Immunologic Research|June 14, 2000
Diverse functions of protease receptor tissue factor in inflammation and metastasisW Ruf, E G Fischer, H Y Huang, et al.
The Journal of Biological Chemistry|November 15, 1996
Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migrationM Yebra, G C Parry, S Strömblad, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
Proteases and protease inhibitors in tumor progressionY A DeClerck, S Imren, A M Montgomery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Suppression of human prostate carcinoma metastases in severe combined immunodeficient mice by interleukin 2 immunocytokine therapyC S Dolman, B M Mueller, H N Lode, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 11, 2000
Reversible regulation of tissue factor-induced coagulation by glycosyl phosphatidylinositol-anchored tissue factor pathway inhibitorI Ott, Y Miyagi, K Miyazaki, et al.
Biochemistry|January 28, 1992
Activation of methotrexate-alpha-alanine by carboxypeptidase A-monoclonal antibody conjugateE Haenseler, A Esswein, K S Vitols, et al.
Pageof 5